A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

Clinical trial NCT00966004 · COMPLETED

Trial details

NCT number: NCT00966004
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2009-07-24
Primary completion: 2010-02-15
Enrollment: 1139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.